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Galectins are characterized by their binding afﬁnity for β-galactosides, a unique binding
site sequence motif, and wide taxonomic distribution and structural conservation in ver-
tebrates, invertebrates, protista, and fungi. Since their initial description, galectins were
considered to bind endogenous (“self”) glycans and mediate developmental processes
and cancer. In the past few years, however, numerous studies have described the diverse
effects of galectins on cells involved in both innate and adaptive immune responses, and the
mechanistic aspects of their regulatory roles in immune homeostasis. More recently, how-
ever, evidence has accumulated to suggest that galectins also bind exogenous (“non-self”)
glycans on the surface of potentially pathogenic microbes, parasites, and fungi, suggest-
ing that galectins can function as pattern recognition receptors (PRRs) in innate immunity.
Thus, a perplexing paradox arises by the fact that galectins also recognize lactosamine-
containing glycans on the host cell surface during developmental processes and regulation
of immune responses. According to the currently accepted model for non-self recognition,
PRRs recognize pathogens via highly conserved microbial surface molecules of wide dis-
tribution such as LPS or peptidoglycan (pathogen-associated molecular patterns; PAMPs),
which are absent in the host. Hence, this would not apply to galectins, which apparently
bind similar self/non-self molecular patterns on host and microbial cells.This paradox under-
scores ﬁrst, an oversimpliﬁcation in the use of the PRR/PAMP terminology. Second, and
most importantly, it reveals signiﬁcant gaps in our knowledge about the diversity of the
host galectin repertoire, and the subcellular targeting, localization, and secretion. Further-
more, our knowledge about the structural and biophysical aspects of their interactions
with the host and microbial carbohydrate moieties is fragmentary, and warrants further
investigation.
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INTRODUCTION
The functional interplay between lectins and their “self” or “non-
self” carbohydrate receptors implicated in various aspects of
immune responses of both vertebrates and invertebrates have been
characterized in considerable detail in recent years (Akira et al.,
2001; Liu and Rabinovich, 2005; Ludwig et al., 2006). It is now
ﬁrmly established C-type lectins, ﬁcolins, siglecs, and galectins
are not only key players in innate immune processes that lead to
pathogen recognition, endocytosis, complement activation, and
antigen processing, but are also involved in adaptive immune
functions, including B and T cell clonal selection, maturation,
activation, and apoptosis. In addition, lectins also participate in
other intracellular and extracellular biological processes such as
glycoprotein trafﬁcking, protein folding, cell–cell or cell–ECM
interactions, signal transduction, fertilization, and development
(reviewed in Vasta and Ahmed, 2009). The identiﬁcation of strik-
ingly diverse lectin repertoires in virtually every animal species,
including the presence of multiple lectin families with numer-
ous members and lectin isoforms, has enabled rationalization
of their roles in immunity. Unlike immunoglobulins, however,
lectins do not generate diversity in recognition by genetic recom-
bination and therefore, considerable interest has arisen on the
germline-encoded diversity of the lectin repertoires, the somatic
mechanisms leading to expansion of their ligand recognition
spectrum, and the structural/functional aspects their carbohy-
drate recognition domains (CRDs; Vilches and Parham, 2002;
Garred et al., 2006).
It is now ﬁrmly established that in vertebrates innate immu-
nity carries a substantial burden of the defense functions against
infections disease, and in the past few years the instructive roles
of innate immunity on adaptive immunity have been widely
recognized. Furthermore, invertebrates and protochordates rely
solely on innate immunity for defense against microbial infection.
Thus, great interest has been generated in the structural-functional
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aspects of its various components, particularly on complement,
lectins, and Toll-like receptors (Fujita et al., 2004; Khalturin
et al., 2004; Iliev et al., 2005). Both the Drosophila Toll and the
mammalian Toll-like receptors recognize pathogens via highly
conserved andwidely distributedmicrobial surfacemolecules such
as lipopolysaccharide, ﬂagellin, lipoteichoic acid, or peptidogly-
can (“pathogen-associated molecular patterns”; PAMPs), which
are essential for the microbe but absent in the host. By recognizing
such non-self molecular patterns, these receptors were designated
as “pattern recognition receptors” (PRRs; Medzhitov and Janeway,
2002). Given that non-pathogenic microbes also share these sur-
face molecules it has been suggested that these may be more
accurately described as “microbe-associated molecular patterns”
(MAMPs; Bittel and Robatzek, 2007). More recently, the term
“virulence-associated molecular pattern” (VAMP) has been intro-
duced to describe those factors (e.g., microbial toxins, ﬂagellin)
that enable the host to discriminate pathogenic microbes from the
non-pathogenic ones (Miao and Warren, 2010). Finally, endoge-
nous factors such as nuclear or cytosolic components that are
released during tissue stress or necrosis can trigger inﬂammatory
responses have been designated as “danger-associated molecular
patterns” (DAMPs; Seong and Matzinger, 2004).
THE MANNOSE-BINDING LECTIN AS A PROTOTYPICAL
PATTERN RECOGNITION RECEPTOR
Since the PRR/PAMP paradigm was initially established for Toll
and TLRs, it has been progressively extended to other innate
immune recognition proteins. Among the best-characterized ani-
mal lectins, the mannose-binding lectin (MBL) a member of the
C-type lectin family has been described as a prototypical PRR
(Garred et al., 2006). C-type lectins are characterized by their
Ca2+ requirement for ligand binding and their structural fold
(C-type lectin domain fold, CTLD), and in most family mem-
bers, the presence of multiple, unrelated structural domains in
the polypeptide (Zelensky and Gready, 2005). They comprise
the collectins (MBLs, ﬁcolin, conglutinin, pulmonary surfac-
tant), proteoglycan core proteins, selectins, endocytic receptors,
the mannose-macrophage receptor, and DC-SIGN (Zelensky and
Gready, 2005; Ip et al., 2009). Although some C-type lectins such
as selectins and DC-SIGN bind “self” glycans, others such as col-
lectins recognize exposed sugar ligands on the microbial surface.
Collectins are lectins with a collagenous region linked to the CRD
that recognizes sugars on microbial surfaces, and upon binding to
a serine protease (MBL-associated serine proteases; MASPs) may
activate the complement cascade (Weis et al., 1998; Wallis, 2002;
Nonaka, 2011; Kingeter and Lin, 2012; Figure 1). Several lectins
homologous of MBLs and ﬁcolins,MASPs, and complement com-
ponents have been identiﬁed in invertebrates and ectothermic
vertebrates, suggesting that C-type lectins and the complement
system played a pivotal role in innate immunity long before the
emergence of adaptive immunity in vertebrates (Weis et al., 1998;
Wallis, 2002; Nonaka, 2011). The CTLD fold has a double-loop
structure with its N- and C-terminal β strands (β1, β5) com-
ing close together to form an antiparallel β-sheet (Figure 1A).
The second loop that lies within the domain is long and it enters
and exits the core domain at the same location. Four cysteine
residues (C1–C4), the most conserved residues in the CTLD, form
FIGURE 1 | Recognition and effector activities of the mannose-binding
lectin (MBL). (A) A schematic representation of CTLD organization; (B)
Crystallographic model of CTLD; (C) Ca2+-dependent carbohydrate binding
of CTLD. The CRD recognizes equatorial hydroxyls on C3 and C4 of
non-reducing terminal mannose with participation of the Ca2+ atom. (D)
The MBL trimer binds to ligands that are displayed about 45 Å apart on the
microbial surface, and via association with the MASP) may activate the
complement cascade, leading to opsonization or lysis of the microbe.
disulﬁde bridges at the bases of the loops. The residues C1 and
C4 link β5 and α1 (the whole domain loop), while C2 and C3
residues link β3 and β5 (the long loop region). The rest of the
chain contains two ﬂanking α helices (α1 and α2) and the sec-
ond β-sheet, formed by strands β2, β3, and β4 (Weis et al., 1998;
Feinberg et al., 2000; Liu and Eisenberg, 2002). The long loop
region is involved in Ca2+-dependent carbohydrate binding, and
in domain-swapping dimerization of some CTLDs. Four Ca2+-
binding sites are present in the CTLD structures, of which only
one (site 2) is known to participate in binding to the carbohydrate
ligand (Loeb and Drickamer, 1988; Weis et al., 1991; Feinberg
et al., 2000). Resolution of the structure of the rat MBP-A/
Man6-GalNAc2-Asn complex revealed that a ternary complex is
formed between the protein, the Ca2+ ion bound in site 2, and
the terminal mannose moiety of the oligosaccharide (Weis et al.,
1992). The complex is stabilized by a network of coordination
and hydrogen bonds: oxygen atoms from 4- and 3-hydroxyls of
the mannose form two coordination bonds with the Ca2+ ion
and four hydrogen bonds with the carbonyl side chains that form
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the Ca2+-binding site 2 (Figure 1B). The amino acid residues
ﬂanking the conserved cis-proline in the long loop region, which
are involved in Ca2+-binding site 2 formation, determine the
speciﬁcity for either galactose or mannose (Figure 1C). In most
mannose-binding CTLDs, the sequence of the motif is EPN (E185
and N185 in MBP-A), while in the galactose-speciﬁc CTLDs it is
QPD. The oligomerization of the MBL subunits results in binding
multivalency that enables the protein to recognize ligands that are
displayed 45 Å apart on the microbial surface, thereby increasing
the MBL’s avidity (Figure 1D). The density of the surface ligands
and their scaffolding (as glycoproteins or glycolipids) modulates
afﬁnity of the interaction via negative cooperativity (Dam and
Brewer,2008). Thus, the bindingofMBL tomultiple non-reducing
terminal carbohydrate ligands on the microbial surface, which are
not readily exposed in the mammalian host, leads to agglutina-
tion and immobilization of the potential pathogen. Further, the
interactions of other MBL domains with additional factors such as
the MASP trigger downstream effector functions including com-
plement activation and opsonization or lysis of the agglutinated
microbes (Weis et al., 1998; Nonaka, 2011). In addition to C-type
lectins, other lectins families have been identiﬁed as PRRs, includ-
ing ﬁcolins, F-lectins, pentraxins, and more recently, the galectins
(reviewed in Vasta and Ahmed, 2009).
GALECTINS: A STRUCTURALLY CONSERVED LECTIN FAMILY
Galectins constitute a family of animal lectins deﬁned by their
afﬁnity for β-galactosides, and a characteristic CRD sequence
motif (Cooper, 2002). The galectin family members are widely
distributed in eukaryotic taxa from fungi and sponges to both
protostome and deuterostome lineages of metazoans and from the
structural standpoint are strikingly conserved (Vasta et al., 1999;
Cooper, 2002). Based on their domain organization, galectins have
been classiﬁed in three types: “proto,” “chimera,” and “tandem-
repeat” (Hirabayashi and Kasai, 1993; Figure 2A). Proto-type
galectins contain one CRD per subunit and are non-covalently
linked homodimers. The chimera galectins have a C-terminal
CRD and an N-terminal domain rich in proline and glycine. In
tandem-repeat (TR) galectins, two CRDs are joined by a func-
tional linker peptide. Recently, a novel TR-type galectin with
four CRDs has been described (Tasumi and Vasta, 2007). Proto
and TR types comprise several distinct galectin subtypes, which
have been numbered following the order of their discovery. At
present time, 15 galectin subtypes have been identiﬁed in mam-
mals. Galectin-1, -2, -5, -7, -10, -11, -13, -14, and -15 are proto
type. Galectin-3 is the only chimera type. Galectin-4, -6, -8, -9,
and -12 are TR type. In solution, galectins can form multiva-
lent species in a concentration-dependent equilibrium (Morris
et al., 2004). The association of proto-type galectin monomers
as non-covalently bound dimers via a hydrophobic interphase
is critical for their function in mediating cell–cell or cell–ECM
interactions, lattice formation at the cell surface, and downstream
effector functions (Rabinovich et al., 2002b). For the chimera-
type galectins, oligomerization takes place via the N-terminus
domain to form trimers or pentamers that in the presence of
multivalent oligosaccharides in solution or at the cell surface dis-
play binding cooperativity (Brewer et al., 2002; Rabinovich et al.,
2002b; Dam and Brewer, 2008). Proto-type galectins associate as
FIGURE 2 | Galectin recognition. (A) Schematic representation of galectin
domain organization; (B) Schematic illustration of cis-interactions of proto,
chimera, and tandem repeat galectins with host cell surface glycans. (C)
Schematic illustration of trans-interactions of proto, chimera, and tandem
repeat galectins with host cell surface and microbial glycans. Proto- and
trandem repeat-type galectins can cross-link host and microbial glycans.
Chimera galectins (galectin-3) can recognize microbial glycans but it is not
clear that they can cross-link them to the host cell surface.
non-covalently bound dimers via a hydrophobic interphase, while
the bivalent TR-type galectins can recognize different saccharide
ligands with a single polypeptide, although they can also form
higher order aggregates that enhances their avidity (Liu et al., 2012;
Troncoso et al., 2012). Most galectins are non-glycosylated soluble
proteins, although a few exceptions have transmembrane domains
(Gorski et al., 2002; Lipkowitz et al., 2004). Although galectins lack
a typical secretion signal peptide, they are present not only in the
cytosol and the nucleus, but also in the extracellular space (Cho
and Cummings, 1995). From the cytosol, galectins may be tar-
geted for secretion by non-classicalmechanisms, possibly by direct
translocation across the plasma membrane (Sato and Hughes,
1994; Cleves et al., 1996;Vyakarnam et al., 1997). In the extracellu-
lar space, galectins can bind to glycans at the cell surface and/or the
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extracellular matrix (Elola et al., 2007; Rabinovich and Toscano,
2009) and topotential pathogens (Mercier et al.,2008;Vasta,2009).
Galectins preferentially bind to N-acetyllactosamine (LacNAc;
Galβ1,4GlcNAc) and relateddisaccharides, including lactose (Lac),
T-disaccharide (Galβ1,3GalNAc), and human ABH blood group
oligosaccharides. Thus, glycans that contain N-acetyllactosamine
and polylactosamine chains [(Galβ1,4GlcNAc)n], such as laminin,
ﬁbronectin, lysosome-associatedmembrane proteins, andmucins,
are the preferred endogenous glycans recognized by galectins
(Fang et al., 1993; Seetharaman et al., 1998). The biological func-
tion of a particular galectin, however, may vary from site to site,
depending on the availability of suitable ligands. The binding
properties and biological functions of galectins in the oxida-
tive extracellular environment, however, may depend on their
immediate binding to ligand, which prevents the oxidation of
free cysteine residues, as well as galectin susceptibility to prote-
olysis (Lobsanov et al., 1993; Liao et al., 1994). The binding of
galectins to cell surface β-galactoside-containing glycolipids and
glycoproteins can lead to the formation of lattices that cluster
these ligands into lipid raft microdomains required for optimal
transmission of signals relevant to cell function (Brewer et al.,
2002; Partridge et al., 2004; Rabinovich et al., 2007b; Figures 2B
and C). Galectin-mediated lipid raft assembly may modulate
turnover of endocytic receptors, signal transduction pathways
leading to T cell activation and cytokine secretion, or apoptosis,
B cell maturation, activation and tolerance, and neutrophil acti-
vation leading to phagocytosis, oxidative burst, and protease and
cytokine release. Thus, galectin-glycoprotein lattices at the cell sur-
face have been proposed to function as an “on-an-off switch” that
regulates cell proliferation, differentiation and survival, includ-
ing immune cell responsiveness and tolerance (Brewer et al., 2002;
Dam and Brewer, 2008).
Among mammalian galectins, gene organization and primary
structures of the encoded proteins are substantially conserved
(Figure 3A). Prior to or during early in chordate evolution,
duplication of a mono-CRD galectin gene would have led to a
bi-CRD galectin gene, in which the N- and C-terminal CRDs
subsequently diverged into two different subtypes, deﬁned by
exon–intron structure (F4-CRD and F3-CRD). All vertebrate
single-CRD galectins belong to either the F3 (e.g., gal-1, -2, -3,
-5) or F4 (e.g., gal-7, -10, -13, -14) subtype, whereas TR galectins
such as gal-4, -6, -8, -9, and -12 contain both F4 and F3 sub-
types (Houzelstein et al., 2004). However, phylogenetic analysis
of the galectin (CvGal) from the eastern oyster Crassostrea vir-
ginica, that displays four tandemly arrayed CRDs, revealed that
these are closely related to the single CRD galectins, suggesting
that the CvGal gene is the product of two consecutive gene dupli-
cations of a single-CRD galectin gene (Tasumi and Vasta, 2007;
Figure 3B). Like for C- and F-type lectins, most mammals are
endowed with a complex galectin repertoire, including members
that exhibit multiple isoforms and more or less subtle variations
in carbohydrate speciﬁcity, which together with a certain degree
of plasticity in sugar binding of each CRD, suggests a substan-
tial diversity in recognition properties (Sparrow et al., 1987; Zhou
and Cummings, 1990; Sato and Hughes, 1992; Fang et al., 1993;
Ahmed et al., 2002; Shoji et al., 2003). In general, ectothermic
vertebrates and invertebrates, and earlier taxa such as parazoa
FIGURE 3 | Gene organization and phylogeny of galectins. (A) Genomic
structures of galectin-1 or galectin-1 like protein from human, murine,
chicken, and zebraﬁsh (Danio rerio). Coding sequences (exons) are
represented by boxes, with their sizes noted above each box. Intron sizes
are shown below. (B) Phylogenetic analysis of invertebrate galectins
modiﬁed based onTasumi and Vasta (2007). The unrooted tree constructed
by the N-J distance method is shown.
(sponges), fungi, and protista appear to have a smaller galectin
repertoire. The presence of a galectin fold in the protistan par-
asite Toxoplasma gondii, and galectin-like proteins in the fungus
Coprinopsis cinerea and in the sponge Geodia cydonium reveals
the early emergence and structural conservation of galectins in
eukaryotic evolution (Saouros et al., 2005; Walser et al., 2005;
Stalz et al., 2006). Among the ectothermic vertebrates, proto-type
galectins have been characterized in toads (Bufo arenarum), frogs
(Rana catesbeiana,Xenopus laevis), salamanders (Ambystomamex-
icanum), and zebraﬁsh, among numerous other species (Ahmed
et al., 1996, 2004; Vasta et al., 1997; Cooper, 2002; Shoji et al.,
2003). The proto-type galectin from B. arenarum resembles the
mammalian galectin-1 with respect to its carbohydrate-binding
proﬁles and its carbohydrate-binding sequence motif (all nine
residues responsible for carbohydrate binding are present: His45,
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Asn47, Arg49, His53, Asp55, Asn62, Trp69, Glu72, and Arg74;
Ahmed et al., 1996). The structures of the B. arenarum galectin
complexed with LacNAc or TDG further support this close simi-
larity (Bianchet et al., 2000). Multiple proto-type galectins from
X. laevis and zebraﬁsh contain all the above nine amino acid
residues for carbohydrate binding, and are likely to exhibit a bind-
ing proﬁle similar to the mammalian galectin-1. Some divergent
family members exhibit unique features, ranging from sequence
replacements in theCRD tomajor structural differences. In a proto
galectin from X. laevis, His52 and Arg73 (numbered as the bovine
galectin-1) are replaced by Ser and Lys, respectively (Marschal
et al., 1992; Shoji et al., 2003), leading to a distinct sugar-binding
proﬁle (Marschal et al., 1992; Ahmed and Vasta, 1994). In con-
gerin I, a galectin from the conger eel Conger myriaster, one of
the β strands is exchanged between the two subunits (Shirai et al.,
1999, 2002). This “strand-swap” contributes to stabilize the dimer
by increasing inter-subunit interactions, and perhaps explains the
high thermostability of the protein. CGL2, a galectin from the
fungus Coprinus cinereus forms a tetramer characterized by two
perpendicular twofold axes of rotation,with theC-terminal amino
acids of the four monomers meeting at the center of the tetramer
interface (Walser et al., 2004). Furthermore, some galectin-like
proteins such as the mammalian lens crystalline protein GRIFIN
(galectin-related inter-ﬁber protein) and the galectin-related pro-
tein GRP (previously HSPC159; hematopoietic stem cell pre-
cursor) lack carbohydrate-binding activity, and are considered
products of evolutionary co-option (Ogden et al., 1998; Ahmed
and Vasta, 2008).
Resolution of the structure of galectin-1–LacNAc complex
revealed a jellyroll topology typical of legume lectins, and enabled
the identiﬁcation of the amino acid residues and the hydroxyl
groups of the ligands that participate in protein–carbohydrate
interactions (Lobsanov et al., 1993; Liao et al., 1994; Bianchet et al.,
2000). The subunit of galectin-1 is composed of an 11-strand
antiparallel β-sandwich and contains a single CRD (Figure 4A).
The carbohydrate binding site is formed by three continuous con-
cave strands (β4–β6) containing all important residues such as his-
tidine 44, asparagine 46, arginine 48, histidine 52, asparagine 61,
tryptophan 68, glutamic acid 71, and arginine 730 that are involved
in direct interactions with LacNAc (Liao et al., 1994; Figure 4B).
Additional interactions of water molecules are involved in bridg-
ing the nitrogen of the NAc group with His52, Asp54, and Arg73
resulting in the increased afﬁnity of LacNAc over Lac. Unlike
galectin-1, galectin-3 has an extended carbohydrate-binding site
formed by a cleft open at both ends, in which the LacNAc is
positioned in such a way that the reducing end of the LacNAc
(GlcNAc) is open to solvent, but the non-reducing Gal moiety is
in close proximity to residues in the β3 strand (Seetharaman et al.,
1998). The extended binding site leads to increased afﬁnity for
glycans with multiple lactosamine units, and with their substitu-
tion of the non-reducing terminal galactose moiety such as ABH
blood group oligosaccharides [Fucα1, 2; GalNAcα1,3(Fucα1,2);
and Galα1,3(Fucα1,2)]. Thermodynamic approaches have been
used not only to assess the galectins’ carbohydrate-binding prop-
erties, but also the oligomeric organization of the protein. On
microcalorimetric studies, the dissociation constants for the inter-
actions of bovine galectin-1 with the preferred ligands (lactose,
FIGURE 4 | Structures of bovine galectin-1 and Bufo arenarum
galectin-1 like protein. (A)The ribbon diagram shows the overlap of the
toad (B. arenarum) galectin-1 like protein (blue, PDB 1GAN) and bovine (Bos
taurus) galectin-1 (yellow, PDB 1slt) in complex with LacNAc (stick
representation). (B) Carbohydrate-binding sites of B. arenarum galectin-1
like protein (blue) and bovine galectin-1 (yellow). The interactions of amino
acid residues with LacNAc are shown for the bovine galectin-1. The OH at
C4’ of Gal (in LacNAc) makes hydrogen bond interactions with the highly
conserved residues His44, Asn46, and Arg48. The OH at C6’ makes similar
interactions with the Asn61 and Glu71. Trp68 participates in a stacking
interaction with the Gal ring carbons and restricts orientation of the OH at
C4’ to the axial form. In GlcNAc moiety of the LacNAc, the hydrogen bond
interactions are involved with the protein through the C3-OH with Agr48,
Glu71, and Arg73. Additional interactions are involved via a water molecule
that bridges the nitrogen of the NAc group with His52, Asp54, and Arg73.
(C) Drgal1-L2 (green) was modeled at the SWISS-MODEL Protein
Modeling Server (http://swissmodel.expasy.org) based on the bovine
galectin-1 structure (yellow, PDB 1slt). All nine residues that form the
carbohydrate-binding cassette in mammalian galectin-1 are present in the
putative binding site of Drgal1-L2. All side chains of these residues were
within 0.5 Å of the equivalent side chains of the bovine galectin-1. (D) C.
elegans 16-kDa galectin (Lec-6; shown in green) was modeled at the
SWISS-MODEL Protein Modeling Server (http://swissmodel.expasy.org)
based on the bovine galectin-1 structure (shown in yellow, PDB 1slt). The
model reveals that a shorter loop (indicated by arrow) between strands 4
and 5 is responsible for its unique binding proﬁle. (E) Alignment of bovine
galectin-1, Ce16 (C. elegans 16 kDa galectin), and CRD1 to -4 of CvGal. (F)
Homology modeling of CvGal CRDs. Bovine galectin-1, CRD-1, -2, -3, and -4
are shown in white, blue, yellow, red, and green, respectively. Numbering
of amino acid residues is based on bovine galectin-1.
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N-acetyllactosamine, thiodigalactoside) were in the range of
10−5 M,with two binding sites permolecule (Schwarz et al., 1998).
The galectin-1 like protein (Drgal-L2) from zebraﬁsh (Danio
rerio) shows extensive sequence homology and structural similar-
ity to vertebrate galectin-1 (Figure 4C). All nine residues that form
the carbohydrate-binding cassette in the mammalian galectin-1
are present in the putative binding site of Drgal1-L2 (Ahmed
et al., 2002). All side chains of these residues were within 0.5 Å
of the equivalent side chains of the bovine galectin-1. Although,
the model of the Caenorhabditis elegans 16-kDa galectin (Ce16)
is similar to the bovine galectin-1 structure (Figure 4D), the car-
bohydrate speciﬁcity of the Ce16 is interesting compared to the
bovine galectin-1 (Ahmed et al., 2002). In Ce16, amino acid sub-
stitutions at positions 46 and 48 (29 and 31 in bovine galectin)
suggest that unlike in bovine galectin-1, these positions (strand
3) are involved in sugar binding. R46 (S29 in the bovine galectin
sequence) interacts with 3′- and 4′-OHof theGal residue. Interest-
ingly, a shorter loop 2 (containing residues 66–69 between strands
4 and 5; Figure 4E) allows E67 to interact with equatorial −OH
at C-3 of GlcNAc (in Galβ1,4GlcNAc) as well as axial −OH at
C-4 of GalNAc (in Galβ1,3GalNAc). The model of the binding
site of the C. elegans 16-kDa galectin also provides a rationale for
the binding to α and β derivatives of Galβ1,3GalNAc (Ahmed
et al., 2002). The sequence alignment of the oyster Crassostrea
virginica galectin CvGal with the bovine galectin-1 revealed that
among nine aa residues responsible for ligand binding, seven are
conserved in all four CvGal CRDs (His44, Asn46, Arg48, Asn61,
Trp68, Glu71, and Arg73; numbers corresponding to the bovine
galectin-1; Tasumi and Vasta, 2007; Figure 4E). Homology mod-
eling of all four CvGal CRDs revealed that the seven conserved
residues from all four CvGal CRDs maintain their positions and
orientations in the binding cleft, relative to the bovine galectin-1
(Figure 4F).
Although relatively conserved from a structural standpoint,
galectins display a surprising functional diversiﬁcation (Figure 5).
Proto-type galectins such as galectin-1 have been reported as
mediators of cell adhesion (Weis et al., 1998; Wallis, 2002), B
cell differentiation (He and Baum, 2004; Martinez et al., 2004),
development (Poirier, 2002), inﬂammation (Rubinstein et al.,
2004), mRNA splicing (Patterson et al., 2004), leukocyte apoptosis
(Perillo et al., 1998; Rabinovich et al., 2002a), neutrophil turnover
(Dias-Barufﬁ et al., 2003), and cancer metastasis (Takenaka et al.,
2004; Liu andRabinovich,2005). Furthermore, given the complex-
ity of the mammalian galectin repertoire and the initial difﬁculties
in identifying clear phenotypes in null mice for selected galectin
family members, it was believed that a certain degree of func-
tional redundancy exists among the members of the galectin
repertoire. More recently, however, as the subtle aspects of their
binding properties and natural ligands are identiﬁed and char-
acterized, and their biological roles are elucidated in increasing
detail, it has become clear that this is not the case (Rabinovich and
Toscano, 2009). Soon after their discovery, galectins were char-
acterized as developmentally regulated proteins, and proposed to
participate in embryogenesis and early development. This was
based on their binding to “self” carbohydrate moieties, such as
polylactosamine-containing glycans, abundant at the cell surface
and the ECM (Figure 5). Chicken galectins have been proposed
to participate in myoblast fusion, whereas murine galectin-1
and galectin-3 have roles in notochord development, somito-
genesis, and development of muscle tissue and central nervous
system (Poirier et al., 1992; Colnot et al., 1996; Puche et al., 1996;
Shoji et al., 2009).
Recent studies show that the gene encoding human galectin-2,
a close relative of galectin-1, is mutated in patients with increased
susceptibility to myocardial infarction, implicating galectin func-
tions in vascular inﬂammation and atherosclerosis (Ozaki et al.,
2004). Further, expression of galectin-3 at the onset of chondriﬁ-
cation suggests its role in bone development, which was supported
by ﬁnding of abnormalities of the hypertrophic zones of cells and
a reduction of the total hypertrophic chondrocytes in galectin-3
null mice (Colnot et al., 2001).
GALECTINS AS REGULATORS OF IMMUNE HOMEOSTASIS
It is now ﬁrmly established that galectins participate in both innate
and adaptive immune responses (Lund and Olafsen, 1999; Sato
et al., 2003; Cartwright et al., 2004; Ohtsubo and Marth, 2006;
Marth and Grewal, 2008; Mascanfroni et al., 2011). Galectins
are ubiquitously expressed and distributed in mammalian tis-
sues, including most cells of the innate (dendritic cells (DCs),
macrophages, mast cells, natural killer cells, gamma/delta T cells,
and B-1 cells) and adaptive (activated B and T cells) immune sys-
tem, and as in other cell types (Li et al., 2011; Cedeno-Laurent and
Dimitroff, 2012).
Since the early 1990s a growing body of experimental (in vivo
and in vitro) evidence has accumulated to support the roles of
galectins expressed by these cells and neighboring stromal cells in
the development and regulation of innate and adaptive immune
homeostasis as well as responses to infectious and allergic chal-
lenge, and cancer. Galectins released by stromal cells in central
compartments contribute to the differentiation of immune cell
precursors. Immune challenge and several pathological conditions
may lead to further activation and differentiation of immune cells,
and modulate the expression and release of galectins to the extra-
cellular space where they may have autocrine or paracrine effects
on immune regulation. Galectins released by immune cells can
oligomerize and form lattices at the cell surface leading to activa-
tion of transmembrane signaling pathways thatmodulate immune
cell functions, including for example, cell adhesion and migration,
T cell apoptosis, and the Th1/Th2 cytokine balance (Rabinovich
and Toscano, 2009). Further, galectins released into the extra-
cellular environment under abnormal situations may themselves
constitute “danger signals,” or by exerting their activities on other
cells, such as mast cells, induce degranulation and release of fac-
tors (e.g., histamine) that represent the “danger signals” leading
to activation of immune mechanisms in the absence of antigenic
challenge (Sato and Nieminen, 2004).
Galectins have diverse effects on cells involved in innate
immune responses (Rabinovich et al., 2007a; Di Lella et al., 2011)
including macrophages and DCs, neutrophils, eosinophils, and
mast cells. Galectin-1 participates in acute and allergic inﬂam-
mation and displays anti-inﬂammatory activities by blocking or
attenuating signaling events that lead to leukocyte inﬁltration,
migration, and recruitment (Guevremont et al., 2004). It also
displays various other effects on innate immunity, including
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FIGURE 5 | Expression, secretion, and functional diversiﬁcation of galectins:
(1) Galectin transcripts are translated in the cytoplasm, and the proteins
can be translocated into the nucleus (2) where they can associate with
ribonucleoproteins. Via unconventional mechanism(s), galectins can be
secreted to the extracellular space (3) where they can function as
pattern recognition receptors for microbial glycans (4), bind to the host
cell surface glycans (5), and cross-link them with ECM glycans (6) thereby,
for example, promoting cell migration. Galectins can also cross-link cell
surface glycans and induce clustering of microdomains and lattice
formation at the cell surface (7) that can trigger signaling cascades,
or cross-link neighboring cells (8) and promote cell–cell interactions/
adhesion.
cell surface exposure of phosphatidylserine in activated neu-
trophils, a process that leads to neutrophil removal by phagocytic
cells without causing apoptosis, and activation/deactivation of
macrophages on a concentration-dependent manner. In con-
trast to the anti-inﬂammatory effects of galectin-1, galectin-3
showspro-inﬂammatory activity. Galectin-3 is normally expressed
in various epithelia and inﬂammatory cells, such as activated
macrophages, DCs, and Kupffer cells, and is upregulated dur-
ing inﬂammation, cell proliferation, and cell differentiation.
Galectin-3 also exhibits anti-apoptotic activity for macrophages
and enhances their interactions with basal lamina glycans, such
as laminin and ﬁbronectin. Taken together, these observations
strongly suggest that galectin-3 enhances macrophage survival,
and positively modulates their recruitment and anti-microbial
activity. Galectin-9 is a selective chemoattractant for eosinophils,
highly expressed in various tissues of the immune system, such as
bone marrow, spleen, thymus, and lymph nodes. Gal-9 released
from activated T cells induces chemotaxis, activation, oxidative
activity, and degranulation of eosinophils, and monocyte-derived
DC maturation (Partridge et al., 2004; Ohtsubo et al., 2005;
Rabinovich et al., 2007b; Stowell et al., 2008). Galectin-9 also pro-
motes tissue inﬂammation through interaction with TIM-3 on
macrophages (Anderson et al., 2007; Di Lella et al., 2011).
Concerning adaptive immune responses galectins function as
regulators of immune cell homeostasis (Cartwright et al., 2004;
Rabinovich et al., 2007a; Ilarregui et al., 2009; Di Lella et al.,
2011). Interactions between stromal cells from the bone marrow
and thymic compartments and lymphocyte precursors are criti-
cal to their development, selection, and further progression to the
periphery. In this regard, interactions mediated by galectins can
modulate B cell maturation and differentiation both at the central
and peripheral immune compartments (Rabinovich et al., 2007a).
Similarly, from their early developmental stages in the thymic com-
partment to the removal of the mature activated T cells in the
periphery, the regulation of T cell survival is critical to a controlled
immune response. Galectin-1 can regulate T cell proliferation and
apoptosis through binding and clustering of lactosamine-rich cell
surface glycoconjugates into segregated membrane microdomains
(Rabinovich and Toscano, 2009). Galectin-1 may have pro- or
anti-apoptotic effects on T cells depending on the developmental
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stage and activation status of the cell, and the microenviron-
ment in which the exposure takes place. An immunoregulatory
circuit involving galectin-1, DCs, and T cells has recently been
described by Rabinovich and his associates (Ilarregui et al., 2009).
Upon exposure to galectin-1, DCs acquired an IL-27-dependent
regulatory function and promoted IL-10-mediated T cell toler-
ance, Th1, and Th17 responses, and suppressed autoimmune
neuroinﬂammation (Ilarregui et al., 2009). Effects of galectin-3
in T cell survival are dependent on whether protein is pro-
duced endogenously (anti-apoptotic) or by exogenous exposure
(pro-apoptotic; Shoji et al., 2003). Several studies suggest that
intracellular galectin-3 confers resistance to apoptosis in response
to chemotherapeutic drugs (Fukumori et al., 2007). In contrast,
extracellular galectin-3 has been shown to induce T cell apoptosis
through caspase-3 activation (Fukumori et al., 2003). Galectin-3
can also modulate T cell activation. Recent studies demonstrated
that endogenous galectin-3 can directly control T cell activation at
sites of immunological synapse (Chen et al., 2009).
Galectins also exert regulatory functions in T cell homeosta-
sis, and signaling cascades triggered by their binding and lattice
formation at the T cell surface has implications in a variety
of downstream events that modulate their differentiation, func-
tional activation, and production of pro- and anti-inﬂammatory
cytokines. The effects of galectins on T cell cytokine synthesis and
secretion ultimately determine the Th1/Th2 polarization of the
immune response. By reducing IFN-γ and IL-2 and enhancing
IL-5, IL-10, and TGF-β production, galectin-1 skews the balance
from a Th1- toward a Th2-polarized response, whereas by reduc-
ing IL-5 levels, galectin-3 drives have the opposite effect (Liu and
Hsu, 2007). Finally, given the regulatory roles of galectins on cells
that mediate both innate and adaptive immune responses, their
effects can be beneﬁcial or detrimental to pathological conditions
that have a basis on exacerbated or depressed immune function,
such as inﬂammatory, allergic, and autoimmune disorders, and
cancer (Liu and Hsu, 2007).
GALECTINS AS PATTERN RECOGNITION RECEPTORS
Insight into themultiple roles of galectins in both innate and adap-
tive immune functions has further expanded recently by discovery
of their ability to directly recognize microbial pathogens (Lund
and Olafsen, 1999), a property shared with other lectin types, such
as C- and F-lectins, ﬁcolins, and pentraxins. The roles of lectins in
recognition of microbial glycans are particularly critical in inver-
tebrates, since these organisms lack immunoglobulins and rely
solely in innate immune mechanisms for recognition of poten-
tial microbial pathogens (Gerwick et al., 2007). This seems to be
the case even in vertebrate taxa, since it has been reported that
susceptibility/resistance to several infectious diseases in humans
are determined by the presence of certain lectin alleles (Fuller
et al., 2004). As discussed above, recognition of “non-self” car-
bohydrate moieties on the surface of microbial pathogens and
parasites by lectins such as the MBL can be rationalized under the
PRR/PAMP concept. In contrast, for those lectins that recognize
endogenous glycans such as galectins, understanding recognition
of microbial glycans requires additional considerations. In some
cases, the ligands on foreign cells can be similar to those displayed
on host cells such as ABH or Le blood group oligosaccharides
(Cartwright et al., 2004; Stowell et al., 2010) and LacNAc present
in viral and bacterial glycans, or structurally different and absent
from the host glycome, such as α1-2-mannans in Candida (Cook
et al., 2005) and LacdiNAc in Schistosoma (Cummings and Nyame,
1999). While the ﬁrst scenario can be conceptualized as molecular
mimicry by the microbial pathogens (Vasta, 2009), understand-
ing the molecular basis of galectin binding to distinct self and
non-self glycans via the same CRD requires further discussion.
In this regard, galectins with tandemly arrayed CRDs such as
the TR galectins from vertebrates, and the 4-CRD galectins from
invertebrates are intriguing both in their binding properties and
functional aspects. Vertebrate TR galectins such as galectin-4, -8,
and -9 differ from the proto and chimera types in that they dis-
play two tandemly arrayed CRDs, and like the binary CRD F-type
lectins, the N- and C-CRDs of TR galectins are similar but not
identical, suggesting that they have distinct recognition proper-
ties (Carlsson et al., 2007). The structures of the TR galectin-4, -8,
and -9havebeenpartially resolved either by crystallizationof NMR
analysis of their isolated N- or C-CRDs and revealed differences
in their binding speciﬁcity and/or afﬁnity for oligosaccharides or
their scaffolding as glycolipids or glycoproteins (Tomizawa et al.,
2005; Nagae et al., 2009; Krejcirikova et al., 2011). The structure
of the N-CRD of the mouse galectin-4 revealed binding sites for
lactosewith different afﬁnities,while the galectin-8 binds preferen-
tially to larger glycans such as glycosphingolipids (Tomizawa et al.,
2005; Nagae et al., 2009; Krejcirikova et al., 2011). The capacity of
TR galectins to cross-link cells with different synthetic glycocon-
jugates (Tomizawa et al., 2005; Ideo et al., 2011) strongly suggests
signiﬁcant differences in the binding properties of their N- and C-
CRDs. From the functional standpoint, the most striking example
is the recognition and killing of Escherichia coli O86 that display B-
blood group oligosaccharides (BGB+ E. coli) by the TR galectin-4
and -8. Mutation of key residues in either CRD revealed that the
C-CRD mediates recognition the BGB+ E. coli but does not affect
its viability, while the N-CRD was not affected, suggesting that
N-CRD might be endowed with killing activity. This was con-
ﬁrmedby examining the binding andkilling activity of the separate
CRDs. This observation suggests that in galectin-4 and -8 the
N- and C-CRDs not only have different recognition properties,
but also they are functionally different in their interactions with
the BGB+ E. coli (Stowell et al., 2009).
A different scenario is presented by the recognition of gly-
cans on the phagocyte (self) and parasite (non-self) surface by
the oyster galectin CvGal (Tasumi and Vasta, 2007). Although the
four CRDs of CvGal are not identical, homology modeling sug-
gests that the minor differences in sequence among the CRDs do
not result in signiﬁcant differences in binding properties. There-
fore, the cross-linking of similar glycans on the host phagocytic
cells and on the surface of the parasite trophozoite by CRDs of
similar binding properties can only be rationalized by the cross-
linking of similar self and non-self glycans by the folding of the
4-CRD polypeptide in a particular geometry, such as a tetrahedral
architecture, where the CRDs are oriented in opposite directions.
A similar model could be proposed by single-CRD proto type and
chimera galectins for which the requisite multivalency and the
spatial arrangement and orientation of the CRDs is achieved by
oligomerization of the single-CRD subunits. However, questions
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about the molecular and structural basis for recognition and bind-
ing to either similar or distinct self or non-self glycans remain
open, and several aspects concerning the protein, the carbohy-
drate ligands, the thermodynamics of lectin–ligand interaction,
and the particular microenvironment in which this interaction
takes place merit further discussion. With regards to the pro-
tein, recognition speciﬁcity and afﬁnity are key aspects of the
lectin–ligand interaction(s) that modulate downstream effector
functions.
In addition to the structural aspects of the primary and
extended carbohydrate binding sites by any CRD in monova-
lent recognition, multiple factors contribute to the energetics of
the interaction, which are further complicated when addressing
multivalent recognition (Ideo et al., 2011). Although as discussed
above for C-, and F-lectins and TR galectins multivalency is a
property of tandemly arrayed CRDs in the lectin polypeptide
subunit, oligomerization of the monomers results in displays of
clustered binding sites that either in their geometry or dimen-
sions can be unique to a particular lectin. For example, the
“bouquet”-like display of binding sites in the MBL trimer results
in multivalency for sugars spaced about 45 Å apart, and increases
avidity of the binding (Rapoport et al., 2008). Although a simi-
lar CRD display is presented in F-type lectins, the geometry of
the ligand display requires sugars spaced 26 Å apart (Bianchet
et al., 2002, 2010). The tissue localization and subcellular com-
partmentalization of lectins can inﬂuence their oligomerization
and in turn, inﬂuence the selective binding of lectins to par-
ticular ligands. For galectins, oligomerization and clustering of
CRDs enables binding to and cross-linking of multivalent glyco-
proteins and glycolipids on the cell surface leading to formation
of microdomains and lattices that signal vial speciﬁc pathways
depending on the glycans and galectins involved (Greenspan,2001;
Rabinovich et al., 2007b; Vokhmyanina et al., 2011). In addition,
the redox properties of the intracellular and extracellular environ-
ments can modulate the activity of lectin–ligand interactions, and
the biological outcome. Most galectins are active in the reducing
environment, but are susceptible to inactivation by oxidation of
their free Cys residues present in the CRD (Stowell et al., 2009).
In the reducing intracellular environment, galectins remain stable,
but upon secretion to the mostly oxidative extracellular space, the
oxidation of the free cysteines compromises not only the bind-
ing activity but also the oligomerization of the galectin subunits
(Stowell et al., 2009). It is noteworthy that the binding of galectin-
9 to the protein disulﬁde isomerase at the cell surface, increases
retention of the enzyme which in turn modulates the redox status
at the plasma membrane (Rabinovich et al., 2007b). In addition
to the lectin quaternary structure as established via structural
or hydrodynamic approaches, higher orders of aggregation may
occur in environments where the lectin concentration reaches
above a certain threshold. The galactosyl-binding lectins DCL-I
and DCL-II from the protochordate Didemnum candidum behave
as homotetramers of 14.5 and 15.5 kDa subunits, respectively,
as revealed by sedimentation velocity and sedimentation equilib-
rium studies. However, even at concentrations below 1 mg/ml, a
positive dependence of the sedimentation coefﬁcient with protein
concentration was observed, suggesting that at increasing con-
centrations the protein associates at orders above the tetramer
(Vasta et al., 1986). For the dimeric galectin-1, further associa-
tion to form tetramers is temperature driven (Dam et al., 2009).
Furthermore, the ligand density at the cell surface can drive
oligomerization of the lectins subunits. In solution, galectin-3
monomers are in equilibrium with higher order oligomers, and
when binding to multivalent glycoproteins or cell surface glycans
theymay recruit additionalmonomers to forma complex of multi-
valent interactions via galectin-3 trimers and pentamers (Ahmad
et al., 2004). The density of the carbohydrate ligands and their
protein or lipid scaffolding context on the cell surface are key fac-
tors that determine lectin recognition and afﬁnity. As proposed
by Dam et al. (2009), in contrast to the well-deﬁned dissocia-
tion constants that describe the binding of lectin monomers to
monovalent glycans, a wide range of relative dissociation con-
stants is needed to describe lectin binding to multivalent surface
glycans, that depends on the density and number of glycans on a
surface and increased negative cooperativity. The authors pro-
pose that this relative afﬁnity should replace the term avidity
(Brewer et al., 2002). Galectin binding to ligand is enthalpically
driven, exhibits enthalpy-entropy compensation, and follows a
van’t Hoff dependence of the binding constant on temperature,
properties that are shared by other lectins. Further, the solva-
tion properties of the CRD, the reorganization or displacement of
the water shell, and the establishment of deﬁned water-mediated
interactions between the protein and the carbohydrate are factors
that affect the thermodynamic aspects of the recognition pro-
cess and stability of the lectin–ligand interaction (Di Lella et al.,
2007; Dam and Brewer, 2010; Echeverria and Amzel, 2011). As
discussed above, many functional properties of lectins such as
the triggering of signaling cascades result from clustered CRDs
recognizing multivalent carbohydrate moieties in different scaf-
folds exposed at the cell surface, followed by the formation
of microdomains and lattices (Rabinovich et al., 2007b). There-
fore, a detailed knowledge of the thermodynamic aspects of
lectin-mediated cross-linking of complex glycans is critical for
the understanding of lectin-mediated selective recognition of self
and non-self ligands. In this regard, recent studies have shown
that high-afﬁnity lectin–mucin interactions are driven by favor-
able binding entropy of binding associated with a “bind and
jump” mechanism. This consists of a dynamic binding process
in which the bound lectins jump from carbohydrate to carbo-
hydrate moiety in the multivalent glycans, which by enhancing
entropic effects facilitates binding and subsequent complex for-
mation (Dam et al., 2009). The factors discussed above suggest
that in the natural context, multiple factors that concern the pro-
tein binding site and lectin oligomerization, the display geometry
and density of the recognized carbohydrate moieties in a partic-
ular protein or lipid scaffold, and the particular properties of the
environment where the lectin–sugar interaction takes place, may
determine not only the binding dynamics and afﬁnity, but also
the lectin’s preference for any one of the (self or non-self) ligands
available.
GALECTINS AS RECEPTORS FOR MICROBIAL
ADHESION AND INFECTION
Whether galectin-mediated recognition is an effective defence
mechanism with a clear beneﬁt for the host is not entirely clear,
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except for a few examples discussed above (Cartwright et al., 2004;
Cook et al., 2005; Kohatsu et al., 2006; Stowell et al., 2010). In
some cases, however, the microbe’s recognition by the vector or
host galectins promotes its adhesion, host cell entry, or infec-
tion persistence, in addition to modulating the host’s immune
responses. Thus, these pathogens and parasites would “sub-
vert” the roles of host or vector galectins as PRRs, to attach
to or gain entry into their cells. This is clearly illustrated by
the participation of galectin interactions in the infection mech-
anisms of HIV. In contrast to the inhibitory role of galectin-1 in
paramixovirus-mediated cell fusion, galectin-1, which is abun-
dant in organs that represent major reservoirs for HIV-1, such
as the thymus and lymph nodes, promotes infection by HIV-1
by facilitating viral attachment to CD4 receptor, and increas-
ing infection efﬁciency (Ouellet et al., 2005; Mercier et al., 2008).
Recent studies showed that galectin-1 enhances HIV adsorption
kinetics on monocyte-derived host macrophages, which facilitates
HIV-1 infectivity by shortening the time required to establish
an infection. Further, galectin-1 would also function as a solu-
ble scavenger receptor and enhance the uptake of the virus by
macrophages, which together with evidence that galectin-1 is
present in the ejaculate and the heads and tails of late spermatids,
led to extend the proposal that galectin-1 may also facilitate sex-
ual transmission of HIV-1 (Mercier et al., 2008). This would take
place through enhancement of viral adsorption kinetics on the
target cells’ surface by the galectin-1 released by sheared ﬁbrob-
lasts and epithelial cells following sex-related microabrasions.
Gal-3 has no effect on HIV-1 adsorption, entry, or infection,
although its expression is upregulated by the HIV Tat protein
in several human cell lines, and in cells infected with other
retroviruses, suggesting that it may participate in regulation of
antiviral immunity (Schroder et al., 1995; Hsu et al., 1996; Fogel
et al., 1999). This underscores the relevance of the subtle dif-
ferences in galectin speciﬁcity and afﬁnity that may determine
very different recognition and effector outcomes. It is note-
worthy that HIV also uses recognition by DC-SIGN, a C-type
lectin, to enter DCs, thereby underscoring the multiple adapta-
tions of the viral glycome for host infection (Hijazi et al., 2011;
van der Vlist et al., 2011).
Several Leishmania species, which spend part of their life
cycle in phlebotomine sandﬂies that constitute vectors for trans-
mission to the vertebrate hosts, are also illustrative examples.
Upon the sandﬂy feeding on blood from an infected host, the
ingested amastigotes mature into promastigotes, which attach to
the insect midgut epithelium to prevent their excretion along
with the digested bloodmeal, and undergo numerous divisions
before differentiating into free-swimming infective metacyclics
(Volf et al., 2007). Although the involvement of the parasite
LPG in this interaction had been suspected from prior stud-
ies, the speciﬁc Phlebotomus papatasi sandﬂy midgut receptor
for the procyclic L. major LPG was identiﬁed as a 35.4-kDa
TR galectin (PpGalec) only expressed by epithelial midgut
cells, and upregulated in the blood-feeding females (Myskova
et al., 2007). Because the binding speciﬁcity of PpGalec is
restricted to Leishmania promastigotes bearing poly-Gal (β1–3)
side chains on their LPG, it was proposed that it is the carbo-
hydrate moiety responsible for speciﬁc binding of L. major to
P. papatasi midgut linings. The assembly of polygalactose epi-
topes is downregulated during L. major metacyclogenesis, and
thus, unable to bind to rPpGalec the free-swimming infec-
tive metacyclic promastigotes are released from the midgut
for transmission from the sandﬂy to the mammalian host
(Myskova et al., 2007).
The protozoan parasite Perkinsus marinus is a facultative intra-
cellular parasite that causes “Dermo” disease in the eastern oyster
Crassostrea virginica, and is responsible for catastrophic damage
to shellﬁsheries and the estuarine environment in North Amer-
ica (Perkins, 1996). The infection mechanism remains unclear,
but it is likely that while ﬁlter feeding, the healthy oysters ingest
P. marinus trophozoites released to the water column by the
infected neighboring individuals. Inside oyster phagocytic cells
(hemocytes), trophozoites resist oxidative killing, proliferate, and
spread throughout the host. It was recently discovered that oys-
ter hemocytes recognize P. marinus via a novel galectin (CvGal)
that displays four canonical galectin CRDs, a domain organiza-
tion unlike any of the known galectin types (Tasumi and Vasta,
2007). Two amino acid residues (His53 and Asp55) that inter-
act with the NAc group via a water molecule are missing in all
four CvGal CRDs resulting in broader carbohydrate speciﬁcity.
CvGal is present in the cytoplasm of circulating granulocytes,
and upon their attachment and spreading it is translocated to
the periphery, secreted, and binds to the cell surface. The remain-
ing galectin is released to the extracellular environment, where it
may bind to all other circulating (non-activated) granulocytes and
hyalinocytes. The most surprising observation, however, was that
the soluble CvGal also binds in a carbohydrate-speciﬁc manner to
a wide variety of microorganisms, phytoplankton components,
and preferentially, to Perkinsus spp. trophozoites, suggesting a
direct role in recognition and opsonization of potential micro-
bial pathogens, as well as algal food. The partial inhibition
of phagocytosis of P. marinus trophozoites by pre-treatment of
hemocytes with anti-CvGal revealed that the hemocyte surface-
associated CvGal is a phagocytosis receptor for P. marinus. Thus,
P. marinus may have evolved to adapt the trophozoite’s glycoca-
lyx to be selectively recognized by the oyster hemocyte CvGal,
thereby subverting the oyster’s innate immune/feeding recog-
nition mechanism to gain entry into the host cells (Tasumi
and Vasta, 2007). A galectin of similar domain organization
was recently identiﬁed in the snail Biomphalaria glabrata, the
intermediate host of the human blood ﬂuke Schistosoma man-
soni, and was proposed to mediate interactions with the parasite
(Yoshino et al., 2008).
A recent study identiﬁed galectin-1 as the receptor for the pro-
tozoan parasite Trichomonas vaginalis (Okumura et al., 2008) the
causative agent of the most prevalent non-viral sexually trans-
mitted human infection in both women and men. As an obligate
extracellular parasite, establishment and persistence of T. vaginalis
infection requires adherence to the host epithelial cell surface.
Like Leishmania spp., T. vaginalis displays a surface LPG rich
in galactose and N-acetyl glucosamine, which is recognized in
a carbohydrate-dependent manner by galectin-1 expressed by the
epithelial cells in the cervical linings, as well as placenta, prostate,
endometrial, and decidual tissue, also colonized by the parasite
(Okumura et al., 2008).
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CONCLUSION
By recognizing highly conserved and widely distributed microbial
surface glycans (PAMPs or MAMPs) which are essential for the
microbe but absent in the host, lectins like the MBL, a member
of the C-type lectin family, ﬁt accurately the deﬁnition of PRR.
Recent studies clearly indicate that also galectins can function as
PRRs that target oligosaccharides on the surface of virus, bacte-
ria, protista and helminth pathogens, and parasites. A perplexing
paradox arises, however, by the fact that galectins also recognize
endogenous lactosamine-containing glycans on the host cell sur-
face during development and regulation of immune homeostasis.
For the TR-type galectins that display two CRDs of similar but
distinct speciﬁcity in a single polypeptide monomer, the binding
and cross-linking of endogenous and exogenous glycans can be
rationalized by the distinct properties of their N- and C-terminus
binding sites. For other lectins such as the proto- and chimera-type
galectins that display a single CRD per monomer, their capacity
to recognize both endogenous and exogenous glycans through the
same binding site, can be explained by taking into consideration
the multiple factors pertaining to the local lectin concentrations
and oligomerization, the geometry of the presentation of the
multivalent carbohydrate ligands on the host or microbial cell
surface, and the properties of the microenvironment in which
interactions take place. For example, in a local microenvironment
where an infection is initiated, the particular concentration of
galectins released to the extracellular space may lead to a distinc-
tive oligomerization, CRD display geometry, and avidity that may
shift galectin binding from the endogenous ligands to the glycans
displayed on the microbial surface in a particular architectural
presentation. It has been proposed that both the microbial and
host glycomes and their receptors continuously evolve to escape
mutual recognition, a process known as the “Red Queen effect”
(reviewed inVasta, 2009), bywhich themicrobe avoids recognition
by the host innate immune receptors (PRRs) and, the host by the
microbial colonization factors (agglutinins, adhesins, and lectins).
Given the key roles played by galectins in early development and
regulation of immune homeostasis by the recognition of “self”gly-
cans, strong functional constraints would prevent galectins from
signiﬁcant evolutionary changes in carbohydrate speciﬁcity. This
is supported by the considerable structural conservation within
this lectin family. Further, with the current evidence about how
pathogens and parasites, which display a remarkable evolutionary
plasticity, efﬁciently subvert the roles of galectins to attach or gain
entrance into the host cells, it seems more plausible that instead
of avoiding recognition by the host, they would have evolved their
glycomes tomimic their hosts’ in a“Trojan horse”model (reviewed
in Vasta, 2009), and rely on the host’s self-recognition molecules
such as galectins for attachment to the vector or host invasion.
It is noteworthy that most of (if not all) these pathogens and
parasites are endowed with diverse and powerful mechanisms to
evade intracellular killing by the host, and/or downregulate down-
stream immune responses. The complex strategies such as glycan
mimicry developed by symbionts, commensals, and microbial
pathogens to successfully colonize, enter, proliferate, and dissemi-
nate within and among their hosts or vectors, are the products of
strong selective pressures that have led to adaptations that ensure
their survival in the most hostile environment of all (Casadevall
and Pirofski, 2000; Hughes and Sperandio, 2008). Thus, these
ﬁne tuned protein–carbohydrate interactions represent a signif-
icant challenge for the development of innovative strategies for
intervention in infectious disease.
ACKNOWLEDGMENTS
The authors’ research reviewed herein was supported by
Grants IOS 1050518, IOB-0618409, and IOS0822257 from the
National Science Foundation, and Grants 1R01GM070589-01 and
5R01GM070589-06 from the National Institutes of Health (NIH)
to Gerardo R. Vasta, grant R41CA141970-01A2 from the NIH to
Haﬁz Ahmed, and grant 1R21AI076797-01A2 from the NIH to
José A. Fernández-Robledo.
REFERENCES
Ahmad, N., Gabius, H.-J., Andre, S.,
Kaltner, H., Sabesan, S., Roy, R., Liu,
B., Macaluso, F., and Brewer, C. F.
(2004). Galectin-3 precipitates as a
pentamer with synthetic multivalent
carbohydrates and forms heteroge-
neous cross-linked complexes. J. Biol.
Chem. 279, 10841–10847.
Ahmed, H., Bianchet, M. A., Amzel, L.
M., Hirabayashi, J., Kasai, K., Giga-
Hama, Y., Tohda, H., and Vasta, G.
R. (2002). Novel carbohydrate speci-
ﬁcity of the 16-kDa galectin from
Caenorhabditis elegans: binding to
blood group precursor oligosaccha-
rides (type 1, type 2, Talpha, and
Tbeta) and gangliosides. Glycobiology
12, 451–461.
Ahmed, H., Du, S. J., O’Leary, N.,
and Vasta, G. R. (2004). Biochem-
ical and molecular characterization
of galectins from zebraﬁsh (Danio
rerio): notochord-speciﬁc expres-
sion of a prototype galectin during
early embryogenesis. Glycobiology 14,
219–232.
Ahmed, H., Pohl, J., Fink, N.
E., Strobel, F., and Vasta, G.
R. (1996). The primary structure
and carbohydrate speciﬁcity of a
beta-galactosyl-binding lectin from
toad (Bufo arenarum Hensel) ovary
reveal closer similarities to the mam-
malian galectin-1 than to the galectin
from the clawed frog Xenopus lae-
vis. J. Biol. Chem. 271, 33083–
33094.
Ahmed, H., and Vasta, G. R. (1994).
Galectins: conservation of function-
ally and structurally relevant amino
acid residues deﬁnes two types of
carbohydrate recognition domains.
Glycobiology 4, 545–548.
Ahmed, H., and Vasta, G. R. (2008).
Unlike mammalian GRIFIN, the
zebraﬁsh homologue (DrGRIFIN)
represents a functional carbohydrate-
binding galectin. Biochem. Biophys.
Res. Commun. 371, 350–355.
Akira, S., Takeda, K., and Kaisho,
T. (2001). Toll-like receptors: crit-
ical proteins linking innate and
acquired immunity. Nat. Immunol. 2,
675–680.
Anderson, A. C., Anderson, D. E., Bre-
goli, L., Hastings, W. D., Kassam,
N., Lei, C., Chandwaskar, R., Kar-
man, J., Su, E. W., Hirashima, M.,
Bruce, J. N., Kane, L. P., Kuchroo,
V. K., and Haﬂer, D. A. (2007). Pro-
motion of tissue inﬂammation by the
immune receptor Tim-3 expressed
on innate immune cells. Science 318,
1141–1143.
Bianchet, M. A., Ahmed, H., Vasta,
G. R., and Amzel, L. M. (2000).
Soluble beta-galactosyl-binding
lectin (galectin) from toad ovary:
crystallographic studies of two
protein-sugar complexes. Proteins 40,
378–388.
Bianchet, M. A., Odom, E. W., Vasta, G.
R., and Amzel, L. M. (2002). A novel
fucose recognition fold involved in
innate immunity. Nat. Struct. Biol. 9,
628–634.
Bianchet, M. A., Odom, E. W., Vasta,
G. R., and Amzel, L. M. (2010).
Structure and speciﬁcity of a binary
tandem domain F-lectin from striped
bass (Morone saxatilis). J. Mol. Biol.
401, 239–252.
Bittel, P., and Robatzek, S. (2007).
Microbe-associated molecular pat-
terns (MAMPs) probe plant immu-
nity. Curr. Opin. Plant Biol. 10,
335–341.
Brewer, C. F., Miceli, M. C., and Baum,
L. G. (2002). Clusters, bundles,
arrays and lattices: novelmechanisms
for lectin-saccharide-mediated cellu-
lar interactions. Curr. Opin. Struct.
Biol. 12, 616–623.
Carlsson, S., Oberg, C. T., Carlsson, M.
C., Sundin, A., Nilsson, U. J., Smith,
D., Cummings, R. D., Almkvist, J.,
Karlsson, A., and Lefﬂer, H. (2007).
Afﬁnity of galectin-8 and its carbohy-
drate recognitiondomains for ligands
www.frontiersin.org July 2012 | Volume 3 | Article 199 | 11
“ﬁmmu-03-00199” — 2012/7/12 — 19:50 — page 12 — #12
Vasta et al. Galectins as self/non-self recognition receptors
in solution and at the cell surface.
Glycobiology 17, 663–676.
Cartwright, J. R., Tharia, H. A., Burns,
I., Shrive, A. K., Hoole, D., and
Greenhough, T. J. (2004). Isolation
and characterisation of pentraxin-
like serum proteins from the com-
mon carp Cyprinus carpio. Dev.
Comp. Immunol. 28, 113–125.
Casadevall, A., and Pirofski, L. A.
(2000). Host-pathogen interactions:
basic concepts of microbial commen-
salism, colonization, infection, and
disease. Infect. Immun. 68, 6511–
6518.
Cedeno-Laurent, F., and Dimitroff, C. J.
(2012). Galectin-1 research in T cell
immunity: past, present and future.
Clin. Immunol. 142, 107–116.
Chen, H. Y., Fermin, A., Vardhana,
S., Weng, I. C., Lo, K. F., Chang,
E. Y., Maverakis, E., Yang, R. Y.,
Hsu, D. K., Dustin, M. L., and Liu,
F. T. (2009). Galectin-3 negatively
regulates TCR-mediated CD4+ T-
cell activation at the immunological
synapse. Proc. Natl. Acad. Sci. U.S.A.
106, 14496–14501.
Cho, M., and Cummings, R. D. (1995).
Galectin-1, a beta-galactoside-
binding lectin in Chinese hamster
ovary cells. II. Localization and
biosynthesis. J. Biol. Chem. 270,
5207–5212.
Cleves, A. E., Cooper, D. N., Barondes,
S. H., and Kelly, R. B. (1996). A new
pathway for protein export in Saccha-
romyces cerevisiae. J. Cell Biol. 133,
1017–1026.
Colnot, C., Ripoche, M. A., Scaerou,
F., Foulis, D., and Poirier, F. (1996).
Galectins in mouse embryogenesis.
Biochem. Soc. Trans. 24, 141–146.
Colnot, C., Sidhu, S. S., Balmain, N.,
and Poirier, F. (2001). Uncoupling of
chondrocyte death and vascular inva-
sion in mouse galectin 3 null mutant
bones. Dev. Biol. 229, 203–214.
Cook, M. T., Hayball, P. J., Nowak, B. F.,
and Hayball, J. D. (2005). The opson-
ising activity of a pentraxin-like pro-
tein isolated from snapper (Pagrus
auratus, Sparidae) serum. Dev. Comp.
Immunol. 29, 703–712.
Cooper, D. N. (2002). Galecti-
nomics: ﬁnding themes in complex-
ity. Biochim. Biophys. Acta 1572,
209–231.
Cummings, R. D., and Nyame, A.
K. (1999). Schistosome glysoconju-
gates. Biochim. Biophys. Acta 1455,
363–374.
Dam, T. K., and Brewer, C. F. (2008).
Effects of clustered epitopes in mul-
tivalent ligand-receptor interactions.
Biochemistry 47, 8470–8476.
Dam, T. K., and Brewer, C. F.
(2010). Lectins as pattern recognition
molecules: the effects of epitope den-
sity in innate immunity. Glycobiology
20, 270–279.
Dam,T.K.,Gerken, T.A., andBrewer,C.
F. (2009). Thermodynamics of mul-
tivalent carbohydrate-lectin cross-
linking interactions: importance of
entropy in the bind and jump mech-
anism. Biochemistry 48, 3822–3827.
Di Lella, S., Marti, M. A., Alvarez, R. M.,
Estrin, D. A., and Ricci, J. C. (2007).
Characterization of the galectin-1
carbohydrate recognition domain in
terms of solvent occupancy. J. Phys.
Chem. B 111, 7360–7366.
Di Lella, S., Sundblad, V., Cerliani, J.
P., Guardia, C. M., Estrin, D. A.,
Vasta, G. R., and Rabinovich, G.
A. (2011). When galectins recognize
glycans: from biochemistry to phys-
iology and back again. Biochemistry
50, 7842–7857.
Dias-Barufﬁ, M., Zhu, H., Cho, M.,
Karmakar, S., Mcever, R. P., and
Cummings, R. D. (2003). Dimeric
galectin-1 induces surface exposure
of phosphatidylserine andphagocytic
recognition of leukocytes without
inducing apoptosis. J. Biol. Chem.
278, 41282–41293.
Echeverria, I., and Amzel, L. M. (2011).
Disaccharide binding to galectin-1:
free energy calculations and molecu-
lar recognition mechanism. Biophys.
J. 100, 2283–2292.
Elola, M. T., Wolfenstein-Todel, C.,
Troncoso, M. F., Vasta, G. R., and
Rabinovich, G. A. (2007). Galectins:
matricellular glycan-bindingproteins
linking cell adhesion, migration, and
survival. Cell. Mol. Life Sci. 64,
1679–1700.
Fang, R., Mantle, M., and Ceri, H.
(1993). Characterization of quail
intestinal mucin as a ligand for
endogenous quail lectin. Biochem. J.
293 (Pt 3), 867–872.
Feinberg, H., Park-Snyder, S., Kolatkar,
A. R., Heise, C. T., Taylor, M. E.,
and Weis, W. I. (2000). Structure
of a C-type carbohydrate recognition
domain from the macrophage man-
nose receptor. J. Biol. Chem. 275,
21539–21548.
Fogel, S., Guittaut, M., Legrand, A.,
Monsigny, M., and Hebert, E. (1999).
The tat protein of HIV-1 induces
galectin-3 expression. Glycobiology 9,
383–387.
Fujita, T., Matsushita, M., and Endo, Y.
(2004). The lectin-complement path-
way – its role in innate immunity
and evolution. Immunol. Rev. 198,
185–202.
Fukumori, T., Kanayama, H. O., and
Raz, A. (2007). The role of galectin-3
in cancer drug resistance. Drug Resist.
Update 10, 101–108.
Fukumori, T., Takenaka, Y., Yoshii, T.,
Kim, H. R., Hogan, V., Inohara, H.,
Kagawa, S., and Raz, A. (2003). CD29
and CD7 mediate galectin-3-induced
type II T-cell apoptosis. Cancer Res.
63, 8302–8311.
Fuller, J. R., Pitzer, J. E., Godwin,
U., Albertino, M., Machon, B. D.,
Kearse, K. P., and Mcconnell, T.
J. (2004). Characterization of the
molecular chaperone calnexin in the
channel catﬁsh, Ictalurus punctatus,
and its association with MHC class
II molecules. Dev. Comp. Immunol.
28, 603–617.
Garred, P., Larsen, F., Seyfarth, J.,
Fujita, R., and Madsen, H. O.
(2006). Mannose-binding lectin and
its genetic variants. Genes Immun. 7,
85–94.
Gerwick, L., Corley-Smith, G., and
Bayne, C. J. (2007). Gene tran-
script changes in individual rainbow
trout livers following an inﬂamma-
tory stimulus. Fish Shellﬁsh Immunol.
22, 157–171.
Gorski, J. P., Liu, F. T., Artigues, A.,
Castagna, L. F., and Osdoby, P.
(2002). New alternatively spliced
form of galectin-3, a member of
the beta-galactoside-binding animal
lectin family, contains a predicted
transmembrane-spanning domain
and a leucine zipper motif. J. Biol.
Chem. 277, 18840–18848.
Greenspan, N. S. (2001). Dimensions
of antigen recognition and levels of
immunological speciﬁcity. Adv. Can-
cer Res. 80, 147–187.
Guevremont, M., Martel-Pelletier, J.,
Boileau, C., Liu, F. T., Richard, M.,
Fernandes, J. C., Pelletier, J. P., and
Reboul, P. (2004). Galectin-3 surface
expression on human adult chon-
drocytes: a potential substrate for
collagenase-3. Ann. Rheum. Dis. 63,
636–643.
He, J., and Baum, L. G. (2004). Presen-
tation of galectin-1 by extracellular
matrix triggers T cell death. J. Biol.
Chem. 279, 4705–4712.
Hijazi, K., Wang, Y., Scala, C., Jeffs,
S., Longstaff, C., Stieh, D., Hag-
garty, B., Vanham, G., Schols, D.,
Balzarini, J., Jones, I. M., Hoxie, J.,
Shattock, R., and Kelly, C. G. (2011).
DC-SIGN increases the afﬁnity of
HIV-1 envelope glycoprotein interac-
tion with CD4. PLoS ONE 6, e28307.
doi: 10.1371/journal.pone.0028307
Hirabayashi, J., and Kasai, K. (1993).
The family of metazoan metal-in-
dependent beta-galactoside-binding
lectins: structure, function and
molecular evolution. Glycobiology 3,
297–304.
Houzelstein, D., Goncalves, I. R., Fad-
den, A. J., Sidhu, S. S., Cooper, D. N.,
Drickamer,K., Lefﬂer,H., andPoirier,
F. (2004). Phylogenetic analysis of the
vertebrate galectin family. Mol. Biol.
Evol. 21, 1177–1187.
Hsu,D. K.,Hammes, S. R., Kuwabara, I.,
Greene, W. C., and Liu, F. T. (1996).
Human T lymphotropic virus-I
infection of human T lymphocytes
induces expression of the beta-
galactoside-binding lectin, galectin-
3. Am. J. Pathol. 148, 1661–1670.
Hughes, D. T., and Sperandio,V. (2008).
Inter-kingdom signalling: commu-
nication between bacteria and their
hosts. Nat. Rev. Microbiol. 6,
111–120.
Ideo, H., Matsuzaka, T., Nonaka,
T., Seko, A., and Yamashita, K.
(2011). Galectin-8-N-domain recog-
nition mechanism for sialylated and
sulfated glycans. J. Biol. Chem. 286,
11346–11355.
Ilarregui, J. M., Croci, D. O., Bianco,
G. A., Toscano, M. A., Salatino,
M., Vermeulen, M. E., Geffner, J.
R., and Rabinovich, G. A. (2009).
Tolerogenic signals delivered by den-
dritic cells to T cells through a
galectin-1-driven immunoregulatory
circuit involving interleukin 27 and
interleukin 10. Nat. Immunol. 10,
981–991.
Iliev, D. B., Roach, J. C., Mackenzie, S.,
Planas, J. V., and Goetz, F. W. (2005).
Endotoxin recognition: in ﬁsh or not
in ﬁsh? FEBS Lett. 579, 6519–6528.
Ip, W. K., Takahashi, K., Ezekowitz,
R. A., and Stuart, L. M. (2009).
Mannose-binding lectin and innate
immunity. Immunol. Rev. 230, 9–21.
Khalturin, K., Panzer, Z., Cooper, M.
D., and Bosch, T. C. (2004). Recogni-
tion strategies in the innate immune
system of ancestral chordates. Mol.
Immunol. 41, 1077–1087.
Kingeter, L. M., and Lin, X. (2012).
C-type lectin receptor-induced NF-
kappaB activation in innate immune
and inﬂammatory responses. Cell.
Mol. Immunol. 9, 105–112.
Kohatsu, L., Hsu, D. K., Jegalian, A. G.,
Liu, F.-T., and Baum, L. G. (2006).
Galectin-3 induces death of Candida
species expressing speciﬁc beta-1,2-
linked mannans. J. Immunol. 177,
4718–4726.
Krejcirikova, V., Pachl, P., Fabry, M.,
Maly, P., Rezacova, P., and Brynda,
J. (2011). Structure of the mouse
galectin-4 N-terminal carbohydrate-
recognition domain reveals the
mechanism of oligosaccharide recog-
nition. Acta Crystallogr. D Biol.
Crystallogr. 67, 204–211.
Li, Y., Feng, J., Geng, S., Wei, H.,
Chen, G., Li, X., Wang, L., Wang,
R., Peng, H., Han, G., and Shen,
B. (2011). The N- and C-terminal
Frontiers in Immunology | Molecular Innate Immunity July 2012 | Volume 3 | Article 199 | 12
“ﬁmmu-03-00199” — 2012/7/12 — 19:50 — page 13 — #13
Vasta et al. Galectins as self/non-self recognition receptors
carbohydrate recognition domains of
galectin-9 contribute differently to its
multiple functions in innate immu-
nity and adaptive immunity. Mol.
Immunol. 48, 670–677.
Liao, D. I., Kapadia, G., Ahmed,
H., Vasta, G. R., and Herzberg,
O. (1994). Structure of S-lectin,
a developmentally regulated verte-
brate beta-galactoside-binding pro-
tein. Proc. Natl. Acad. Sci. U.S.A. 91,
1428–1432.
Lipkowitz, M. S., Leal-Pinto, E., Cohen,
B. E., and Abramson, R. G. (2004).
Galectin 9 is the sugar-regulatedurate
transporter/channel UAT. Glycoconj.
J. 19, 491–498.
Liu, F. T., and Hsu, D. K. (2007). The
role of galectin-3 in promotion of the
inﬂammatory response. Drug News
Perspect. 20, 455–460.
Liu, F. T., and Rabinovich, G. A. (2005).
Galectins as modulators of tumour
progression. Nat. Rev. Cancer 5,
29–41.
Liu, F. T., Yang, R. Y., and Hsu, D.
K. (2012). Galectins in acute and
chronic inﬂammation. Ann. N.Y.
Acad. Sci. 1253, 80–91.
Liu, Y., and Eisenberg, D. (2002). 3D
domain swapping: as domains con-
tinue to swap. Protein Sci. 11, 1285–
1299.
Lobsanov, Y. D., Gitt, M. A., Lefﬂer,
H., Barondes, S. H., and Rini, J.
M. (1993). X-ray crystal structure
of the human dimeric S-Lac lectin,
L-14-II, in complex with lactose at
2.9-A resolution. J. Biol. Chem. 268,
27034–27038.
Loeb, J. A., and Drickamer, K.
(1988). Conformational changes in
the chicken receptor for endocyto-
sis of glycoproteins. Modulation of
ligand-binding activity by Ca2+ and
pH. J. Biol. Chem. 263, 9752–9760.
Ludwig, I. S., Geijtenbeek, T. B., andVan
Kooyk,Y. (2006). Twoway communi-
cation between neutrophils and den-
dritic cells. Curr. Opin. Pharmacol. 6,
408–413.
Lund, V., and Olafsen, J. A. (1999).
Changes in serum concentration of
a serum amyloid P-like pentraxin
in Atlantic salmon, Salmo salar
L., during infection and inﬂamma-
tion. Dev. Comp. Immunol. 23,
61–70.
Marschal, P., Herrmann, J., Lefﬂer, H.,
Barondes, S. H., and Cooper, D. N.
(1992). Sequence and speciﬁcity of
a soluble lactose-binding lectin from
Xenopus laevis skin. J. Biol. Chem.
267, 12942–12949.
Marth, J. D., and Grewal, P. K.
(2008). Mammalian glycosylation in
immunity. Nat. Rev. Immunol. 8,
874–887.
Martinez, V. G., Pellizzari, E. H., Diaz,
E. S., Cigorraga, S. B., Lustig, L., Den-
duchis, B.,Wolfenstein-Todel, C., and
Iglesias, M. M. (2004). Galectin-1,
a cell adhesion modulator, induces
apoptosis of rat Leydig cells in vitro.
Glycobiology 14, 127–137.
Mascanfroni, I. D., Cerliani, J. P.,
Dergan-Dylon, S., Croci, D. O.,
Ilarregui, J. M., and Rabinovich,
G. A. (2011). Endogenous lectins
shape the function of dendritic
cells and tailor adaptive immunity:
mechanisms and biomedical appli-
cations. Int. Immunopharmacol. 11,
833–841.
Medzhitov, R., and Janeway, C. A. Jr.
(2002). Decoding the patterns of self
and nonself by the innate immune
system. Science 296, 298–300.
Mercier, S., St-Pierre, C., Pelletier, I.,
Ouellet, M., Tremblay, M. J., and
Sato, S. (2008). Galectin-1 promotes
HIV-1 infectivity in macrophages
through stabilization of viral adsorp-
tion. Virology 371, 121–129.
Miao, E. A., and Warren, S. E. (2010).
Innate immune detection of bacte-
rial virulence factors via the NLRC4
inﬂammasome. J. Clin. Immunol. 30,
502–506.
Morris, S., Ahmad, N., Andre, S., Kalt-
ner, H., Gabius, H. J., Brenowitz,
M., and Brewer, F. (2004). Quater-
nary solution structures of galectins-
1, -3, and -7. Glycobiology 14,
293–300.
Myskova, J., Svobodova, M., Bever-
ley, S. M., and Volf, P. (2007). A
lipophosphoglycan-independent
development of Leishmania in per-
missive sand ﬂies. Microbes Infect. 9,
317–324.
Nagae, M., Nishi, N., Murata, T., Usui,
T., Nakamura, T., Wakatsuki, S., and
Kato, R. (2009). Structural analysis of
the recognition mechanism of poly-
N-acetyllactosamine by the human
galectin-9 N-terminal carbohydrate
recognition domain. Glycobiology 19,
112–117.
Nonaka, M. (2011). The complement
C3 protein family in invertebrates. ISJ
8, 21–32.
Ogden, A. T., Nunes, I., Ko, K., Wu, S.,
Hines, C. S., Wang, A. F., Hegde, R.
S., and Lang, R. A. (1998). GRIFIN, a
novel lens-speciﬁc protein related to
the galectin family. J. Biol. Chem. 273,
28889–28896.
Ohtsubo, K., and Marth, J. D. (2006).
Glycosylation in cellular mechanisms
of health and disease. Cell 126,
855–867.
Ohtsubo, K., Takamatsu, S., Minowa,
M. T., Yoshida, A., Takeuchi, M.,
and Marth, J. D. (2005). Dietary and
genetic control of glucose transporter
2 glycosylation promotes insulin
secretion in suppressing diabetes. Cell
123, 1307–1321.
Okumura, C. Y., Baum, L. G., and
Johnson, P. J. (2008). Galectin-1 on
cervical epithelial cells is a receptor
for the sexually transmitted human
parasite Trichomonas vaginalis. Cell.
Microbiol. 10, 2078–2090.
Ouellet, M., Mercier, S., Pelletier, I.,
Bounou, S., Roy, J., Hirabayashi, J.,
Sato, S., and Tremblay, M. J. (2005).
Galectin-1 acts as a soluble host fac-
tor that promotes HIV-1 infectivity
through stabilization of virus attach-
ment to host cells. J. Immunol. 174,
4120–4126.
Ozaki, K., Inoue, K., Sato, H., Iida, A.,
Ohnishi, Y., Sekine, A., Odashiro, K.,
Nobuyoshi, M., Hori, M., Nakamura,
Y., and Tanaka, T. (2004). Functional
variation in LGALS2 confers risk of
myocardial infarction and regulates
lymphotoxin-alpha secretion in vitro.
Nature 429, 72–75.
Partridge, E. A., Le Roy, C., Di
Guglielmo, G. M., Pawling, J., Che-
ung, P., Granovsky, M., Nabi, I.
R., Wrana, J. L., and Dennis, J.
W. (2004). Regulation of cytokine
receptors by Golgi N-glycan process-
ing and endocytosis. Science 306,
120–124.
Patterson, R. J., Wang, W., and Wang,
J. L. (2004). Understanding the bio-
chemical activities of galectin-1 and
galectin-3 in the nucleus. Glycoconj.
J. 19, 499–506.
Perillo, N. L., Marcus, M. E., and
Baum, L. G. (1998). Galectins: versa-
tile modulators of cell adhesion, cell
proliferation, and cell death. J. Mol.
Med. (Berl) 76, 402–412.
Perkins, F. O. (1996). The structure
of Perkinsus marinus (Mackin, Owen
and Collier, 1950) Levine, 1978 with
comments on taxonomy and phy-
logeny of Perkinsus spp. J. Shellﬁsh
Res. 15, 67–87.
Poirier, F. (2002). Roles of galectins in
vivo. Biochem. Soc. Symp. 69, 95–103.
Poirier, F., Timmons, P. M., Chan,
C. T., Guenet, J. L., and Rigby, P.
W. (1992). Expression of the L14
lectin during mouse embryogenesis
suggests multiple roles during pre-
and post-implantation development.
Development 115, 143–155.
Puche, A. C., Poirier, F., Hair, M.,
Bartlett, P. F., and Key, B. (1996).
Role of galectin-1 in the developing
mouse olfactory system. Dev. Biol.
179, 274–287.
Rabinovich, G. A., Baum, L. G.,
Tinari, N., Paganelli, R., Natoli,
C., Liu, F. T., and Iacobelli, S.
(2002a). Galectins and their ligands:
ampliﬁers, silencers or tuners of
the inﬂammatory response? Trends
Immunol. 23, 313–320.
Rabinovich, G. A., Liu, F. T., Hirashima,
M., and Anderson, A. (2007a). An
emerging role for galectins in tun-
ing the immune response: lessons
from experimental models of inﬂam-
matory disease, autoimmunity and
cancer. Scand. J. Immunol. 66,
143–158.
Rabinovich, G. A., Rubinstein, N.,
and Toscano, M. A. (2002b).
Role of galectins in inﬂamma-
tory and immunomodulatory pro-
cesses. Biochim. Biophys. Acta 1572,
274–284.
Rabinovich, G. A., and Toscano, M. A.
(2009). Turning “sweet” on immu-
nity: galectin-glycan interactions in
immune tolerance and inﬂamma-
tion. Nat. Rev. Immunol. 9, 338–352.
Rabinovich, G. A., Toscano, M. A.,
Jackson, S. S., and Vasta, G. R.
(2007b). Functions of cell surface
galectin-glycoprotein lattices. Curr.
Opin. Struct. Biol. 17, 513–520.
Rapoport, E. M., Andre, S., Kurmyshk-
ina,O.V., Pochechueva, T.V., Severov,
V. V., Pazynina, G. V., Gabius, H.-J.,
and Bovin, N. V. (2008). Galectin-
loaded cells as a platform for the
proﬁling of lectin speciﬁcity by ﬂu-
orescent neoglycoconjugates: a case
study on galectins-1 and -3 and the
impact of assay setting. Glycobiology
18, 315–324.
Rubinstein, N., Ilarregui, J. M., Toscano,
M. A., and Rabinovich, G. A. (2004).
The role of galectins in the initi-
ation, ampliﬁcation and resolution
of the inﬂammatory response. Tissue
Antigens 64, 1–12.
Saouros, S., Edwards-Jones, B., Reiss,
M., Sawmynaden, K., Cota, E.,
Simpson, P., Dowse, T. J., Jakle,
U., Ramboarina, S., Shivarattan, T.,
Matthews, S., and Soldati-Favre, D.
(2005). A novel galectin-like domain
from Toxoplasma gondii micronemal
protein 1 assists the folding, assem-
bly, and transport of a cell adhe-
sion complex. J. Biol. Chem. 280,
38583–38591.
Sato, A., Mayer, W. E., Overath, P.,
and Klein, J. (2003). Genes encod-
ing putative natural killer cell C-type
lectin receptors in teleostean ﬁshes.
Proc. Natl. Acad. Sci. U.S.A. 100,
7779–7784.
Sato, S., and Hughes, R. C. (1992).
Binding speciﬁcity of a baby ham-
ster kidney lectin for H type I and
II chains, polylactosamine glycans,
and appropriately glycosylated forms
of laminin and ﬁbronectin. J. Biol.
Chem. 267, 6983–6990.
Sato, S., and Hughes, R. C. (1994).
Regulation of secretion and surface
www.frontiersin.org July 2012 | Volume 3 | Article 199 | 13
“ﬁmmu-03-00199” — 2012/7/12 — 19:50 — page 14 — #14
Vasta et al. Galectins as self/non-self recognition receptors
expression of Mac-2, a galactoside-
binding protein of macrophages. J.
Biol. Chem. 269, 4424–4430.
Sato, S., and Nieminen, J. (2004). See-
ing strangers or announcing “dan-
ger”: galectin-3 in two models of
innate immunity. Glycoconj. J. 19,
583–591.
Schroder, H. C., Ushijima, H., Theis,
C., Seve, A. P., Hubert, J., and
Muller, W. E. (1995). Expression of
nuclear lectin carbohydrate-binding
protein 35 in human immunodeﬁ-
ciency virus type 1-infected Molt-3
cells. J. Acquir. Immune Deﬁc. Syndr.
Hum. Retrovirol. 9, 340–348.
Schwarz, F. P., Ahmed, H., Bianchet, M.
A., Amzel, L. M., and Vasta, G. R.
(1998). Thermodynamics of bovine
spleen galectin-1 binding to disaccha-
rides: correlation with structure and
its effect on oligomerization at the
denaturation temperature. Biochem-
istry 37, 5867–5877.
Seetharaman, J., Kanigsberg, A., Slaaby,
R., Lefﬂer, H., Barondes, S. H.,
and Rini, J. M. (1998). X-ray crys-
tal structure of the human galectin-3
carbohydrate recognition domain at
2.1-A resolution. J. Biol. Chem. 273,
13047–13052.
Seong, S.-Y., and Matzinger, P. (2004).
Hydrophobicity: an ancient damage-
associated molecular pattern that ini-
tiates innate immune responses. Nat.
Rev. Immunol. 4, 469–478.
Shirai, T., Matsui, Y., Shionyu-
Mitsuyama, C., Yamane, T., Kamiya,
H., Ishii, C., Ogawa, T., and
Muramoto, K. (2002). Crystal struc-
ture of a conger eel galectin (con-
gerin II) at 1.45A resolution: impli-
cation for the accelerated evolution
of a new ligand-binding site follow-
ing gene duplication. J.Mol. Biol. 321,
879–889.
Shirai, T., Mitsuyama, C., Niwa, Y.,
Matsui, Y., Hotta, H., Yamane, T.,
Kamiya, H., Ishii, C., Ogawa, T.,
and Muramoto, K. (1999). High-
resolution structure of the conger
eel galectin, congerin I, in lactose-
liganded and ligand-free forms:
emergence of a new structure class
by accelerated evolution. Structure 7,
1223–1233.
Shoji, H., Deltour, L., Nakamura,
T., Tajbakhsh, S., and Poirier, F.
(2009). Expression pattern and role
of Galectin1 during early mouse
myogenesis. Dev. Growth Differ. 51,
607–615.
Shoji, H., Nishi, N., Hirashima, M., and
Nakamura, T. (2003). Characteriza-
tion of the Xenopus galectin family.
Three structurally different types as
in mammals and regulated expres-
sion during embryogenesis. J. Biol.
Chem. 278, 12285–12293.
Sparrow, C. P., Lefﬂer, H., and Baron-
des, S. H. (1987). Multiple solu-
ble beta-galactoside-binding lectins
from human lung. J. Biol. Chem. 262,
7383–7390.
Stalz, H., Roth, U., Schleuder, D.,
Macht, M., Haebel, S., Strupat,
K., Peter-Katalinic, J., and Hanisch,
F. G. (2006). The Geodia cydo-
nium galectin exhibits prototype
and chimera-type characteristics and
a unique sequence polymorphism
within its carbohydrate recognition
domain. Glycobiology 16, 402–414.
Stowell, S. R., Arthur, C. M., Dias-
Barufﬁ, M., Rodrigues, L. C., Gour-
dine, J. P., Heimburg-Molinaro, J., Ju,
T., Molinaro, R. J., Rivera-Marrero,
C., Xia, B., Smith, D. F., and Cum-
mings, R. D. (2010). Innate immune
lectins kill bacteria expressing blood
group antigen. Nat. Med. 16,
295–301.
Stowell, S. R., Cho, M., Feasley, C. L.,
Arthur, C. M., Song, X., Colucci, J. K.,
Karmakar, S., Mehta, P., Dias-Barufﬁ,
M., Mcever, R. P., and Cummings, R.
D. (2009). Ligand reduces galectin-1
sensitivity to oxidative inactivationby
enhancing dimer formation. J. Biol.
Chem. 284, 4989–4999.
Stowell, S. R., Qian, Y., Karmakar, S.,
Koyama, N. S., Dias-Barufﬁ, M., Lef-
ﬂer,H.,Mcever, R. P., andCummings,
R. D. (2008). Differential roles of
galectin-1 and galectin-3 in regulat-
ing leukocyte viability and cytokine
secretion. J. Immunol. 180, 3091–
3102.
Takenaka, Y., Fukumori, T., and Raz,
A. (2004). Galectin-3 and metastasis.
Glycoconj. J. 19, 543–549.
Tasumi, S., and Vasta, G. R. (2007). A
galectin of unique domain organi-
zation from hemocytes of the East-
ern oyster (Crassostrea virginica) is
a receptor for the protistan parasite
Perkinsus marinus. J. Immunol. 179,
3086–3098.
Tomizawa, T., Kigawa, T., Saito,
K., Koshiba, S., Inoue, M., and
Yokoyama, S. (2005). Solution struc-
ture of the C-terminal gal-bind
lectin domain from human galectin-
4. Structural Genomics and Pro-
teomics Initiative (RSGI), Riken.
Troncoso, M. F., Elola, M. T., Croci,
D. O., and Rabinovich, G. A. (2012).
Integrating structure and function
of “tandem-repeat” galectins. Front.
Biosci. (Schol Ed) 4, 864–887.
van der Vlist, M., van der Aar, A. M.,
Gringhuis, S. I., and Geijtenbeek, T.
B. (2011). Innate signaling in HIV-
1 infection of dendritic cells. Curr.
Opin. HIV AIDS 6, 348–352.
Vasta, G. R. (2009). Roles of galectins
in infection. Nat. Rev. Microbiol. 7,
424–438.
Vasta, G. R., and Ahmed, H. (2009).
Animal Lectins: A Functional View.
Boca Raton, FL: CRC Press (Taylor
& Francis Group).
Vasta, G. R., Ahmed, H., Amzel, L. M.,
and Biahchet,M.A. (1997). Galectins
from amphibian species: carbohy-
drate speciﬁcity, molecular structure
and evolution. Trends Blycosci. Gly-
cotechnol. 9, 131–144.
Vasta, G. R., Hunt, J. C., Marchalonis, J.
J., and Fish,W.W. (1986). Galactosyl-
binding lectins from the tunicate
Didemnum candidum. Puriﬁcation
and physicochemical characteriza-
tion. J. Biol. Chem. 261, 9174–9181.
Vasta, G. R., Quesenberry, M., Ahmed,
H., and O’Leary, N. (1999). C-
type lectins and galectins mediate
innate and adaptive immune func-
tions: their roles in the comple-
ment activation pathway. Dev. Comp.
Immunol. 23, 401–420.
Vilches, C., and Parham, P. (2002). KIR:
diverse, rapidly evolving receptors of
innate and adaptive immunity. Annu.
Rev. Immunol. 20, 217–251.
Vokhmyanina, O. A., Rapoport, E. M.,
Ryzhov, I. M., Korchagina, E. Y.,
Pazynina, G. V., Severov, V. V., Kalt-
ner, H., Andre, S., Gabius, H. J., and
Bovin, N. V. (2011). Carbohydrate
speciﬁcity of chicken and human
tandem-repeat-type galectins-8 in
composition of cells. Biochemistry
(Mosc) 76, 1185–1192.
Volf, P., Benkova, I., Myskova, J.,
Sadlova, J., Campino, L., and
Ravel, C. (2007). Increased trans-
mission potential of Leishmania
major/Leishmania infantum hybrids.
Int. J. Parasitol. 37, 589–593.
Vyakarnam, A., Dagher, S. F., Wang,
J. L., and Patterson, R. J. (1997).
Evidence for a role for galectin-1 in
pre-mRNA splicing. Mol. Cell. Biol.
17, 4730–4737.
Wallis, R. (2002). Structural and func-
tional aspects of complement acti-
vation by mannose-binding protein.
Immunobiology 205, 433–445.
Walser, P. J., Haebel, P. W., Kunzler, M.,
Sargent, D., Kues, U., Aebi, M., and
Ban, N. (2004). Structure and func-
tional analysis of the fungal galectin
CGL2. Structure 12, 689–702.
Walser, P. J., Kues,U.,Aebi,M., andKun-
zler, M. (2005). Ligand interactions
of the Coprinopsis cinerea galectins.
Fungal Genet. Biol. 42, 293–305.
Weis, W. I., Drickamer, K., and Hen-
drickson, W. A. (1992). Structure of
a C-type mannose-binding protein
complexed with an oligosaccharide.
Nature 360, 127–134.
Weis, W. I., Kahn, R., Fourme, R.,
Drickamer, K., and Hendrickson, W.
A. (1991). Structure of the calcium-
dependent lectin domain from a
rat mannose-binding protein deter-
mined by MAD phasing. Science 254,
1608–1615.
Weis, W. I., Taylor, M. E., and Drick-
amer, K. (1998). The C-type lectin
superfamily in the immune system.
Immunol. Rev. 163, 19–34.
Yoshino, T. P., Dinguirard, N.,
Kunert, J., and Hokke, C. H.
(2008). Molecular and functional
characterization of a tandem-repeat
galectin from the freshwater snail
Biomphalaria glabrata, intermedi-
ate host of the human blood ﬂuke
Schistosoma mansoni. Gene 411,
46–58.
Zelensky,A. N., andGready, J. E. (2005).
The C-type lectin-like domain super-
family. FEBS J. 272, 6179–6217.
Zhou, Q., and Cummings, R. D. (1990).
The S-type lectin from calf heart
tissue binds selectively to the car-
bohydrate chains of laminin. Arch.
Biochem. Biophys. 281, 27–35.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 26April 2012; accepted: 26 June
2012; published online: 13 July 2012.
Citation: Vasta GR, Ahmed H, Nita-
Lazar M, Banerjee A, Pasek M, Shridhar
S, Guha P and Fernández-Robledo JA
(2012) Galectins as self/non-self recog-
nition receptors in innate and adap-
tive immunity: an unresolved paradox.
Front. Immun. 3:199. doi: 10.3389/
ﬁmmu.2012.00199
This article was submitted to Frontiers in
Molecular Innate Immunity, a specialty
of Frontiers in Immunology.
Copyright © 2012 Vasta, Ahmed, Nita-
Lazar, Banerjee, Pasek, Shridhar, Guha
and Fernández-Robledo. This is an open-
access article distributed under the terms
of the Creative Commons Attribution
License, which permits use, distribution
and reproduction in other forums, pro-
vided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
Frontiers in Immunology | Molecular Innate Immunity July 2012 | Volume 3 | Article 199 | 14
